Structure-Based β-Secretase (BACE1) Inhibitors

Current Pharmaceutical Design - United Arab Emirates
doi 10.2174/13816128113199990607
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Targeting the Β Secretase BACE1 for Alzheimer's Disease Therapy

The Lancet Neurology
Neurology
2014English

Identification of Potent Inhibitors for Β-Secretase Through Structure Based Virtual Screening and Molecular Dynamics Simulations

Journal of Clinical and Scientific Research
2013English

Design, Synthesis, and Crystal Structure of Hydroxyethyl Secondary Amine-Based Peptidomimetic Inhibitors of Human B-Secretase

English

In Silico Discovery of B-Secretase Inhibitors

English

Γ-Secretase Inhibitors and Modulators for Alzheimer’s Disease

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2011English

Chemical Diversity of Β-Secretase Inhibitors From Natural Resources

Natural Product Communications
PharmacologyComplementaryPlant ScienceAlternative MedicineMedicineDrug Discovery
2019English

Structure-Based Design of Inhibitors of CXCR4.

English

Structure-Based Search for New Inhibitors of Cholinesterases

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2013English

Highly Selective and Potent Human Β-Secretase 2 (BACE2) Inhibitors Against Type 2 Diabetes: Design, Synthesis, X-Ray Structure and Structure-Activity Relationship Studies

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy